203 related articles for article (PubMed ID: 17510395)
1. Mitochondrial genetic background modifies breast cancer risk.
Bai RK; Leal SM; Covarrubias D; Liu A; Wong LJ
Cancer Res; 2007 May; 67(10):4687-94. PubMed ID: 17510395
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer.
Darvishi K; Sharma S; Bhat AK; Rai E; Bamezai RN
Cancer Lett; 2007 May; 249(2):249-55. PubMed ID: 17081685
[TBL] [Abstract][Full Text] [Related]
3. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
Chen P; Liang J; Wang Z; Zhou X; Chen L; Li M; Xie D; Hu Z; Shen H; Wang H
Clin Cancer Res; 2008 Sep; 14(18):5931-7. PubMed ID: 18794107
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis.
Rego-Pérez I; Fernández-Moreno M; Fernández-López C; Arenas J; Blanco FJ
Arthritis Rheum; 2008 Aug; 58(8):2387-96. PubMed ID: 18668590
[TBL] [Abstract][Full Text] [Related]
5. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
6. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
Cebrian A; Pharoah PD; Ahmed S; Smith PL; Luccarini C; Luben R; Redman K; Munday H; Easton DF; Dunning AM; Ponder BA
Cancer Res; 2006 Jan; 66(2):1225-33. PubMed ID: 16424062
[TBL] [Abstract][Full Text] [Related]
7. SNPs in ultraconserved elements and familial breast cancer risk.
Yang R; Frank B; Hemminki K; Bartram CR; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Arnold N; Weber BH; Niederacher D; Meindl A; Burwinkel B
Carcinogenesis; 2008 Feb; 29(2):351-5. PubMed ID: 18174240
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women.
Sangrajrang S; Schmezer P; Burkholder I; Waas P; Boffetta P; Brennan P; Bartsch H; Wiangnon S; Popanda O
Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186
[TBL] [Abstract][Full Text] [Related]
9. Involvement of mitochondrial DNA sequence variations and respiratory activity in late complications following radiotherapy.
Alsbeih GA; Al-Harbi NM; El-Sebaie MM; Al-Rajhi NM; Al-Hadyan KS; Abu-Amero KK
Clin Cancer Res; 2009 Dec; 15(23):7352-60. PubMed ID: 19920115
[TBL] [Abstract][Full Text] [Related]
10. Germline HVR-II mitochondrial polymorphisms associated with breast cancer in Tunisian women.
Yacoubi Loueslati B; Troudi W; Cherni L; Rhomdhane KB; Mota-Vieira L
Genet Mol Res; 2010 Aug; 9(3):1690-700. PubMed ID: 20812191
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
Kotsopoulos J; Zhang WW; Zhang S; McCready D; Trudeau M; Zhang P; Sun P; Narod SA
Breast Cancer Res Treat; 2008 Dec; 112(3):585-93. PubMed ID: 18204969
[TBL] [Abstract][Full Text] [Related]
12. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.
Rohan TE; Li SQ; Hartwick R; Kandel RA
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1316-23. PubMed ID: 16835330
[TBL] [Abstract][Full Text] [Related]
13. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
17. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
[TBL] [Abstract][Full Text] [Related]
19. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]